Diagnostic performance of machine learning-based radiomics models for predicting epidermal growth factor receptor mutation status in lung adenocarcinoma in Chinese patients: A systematic review and meta-analysis.
CT scan analysis using machine learning could replace biopsies to determine which lung cancer patients benefit from targeted drugs.
EGFR mutation status determines first-line targeted therapy eligibility in lung adenocarcinoma but requires tissue biopsy, which is not always feasible. This meta-analysis synthesizes evidence for ML-based CT radiomics as a non-invasive surrogate, reporting pooled diagnostic performance across multiple studies in Chinese patient populations.
What the study was
- Study design
- systematic_review
- Population
- Lung adenocarcinoma patients in Chinese populations
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- J Int Med Res
Why it surfaced
High-priority: EGFR-targeted therapy is a precision oncology core topic; non-invasive mutation prediction addresses real clinical gaps in biopsy accessibility; systematic review with meta-analysis provides highest level of aggregated evidence; directly relevant to AI diagnostics and genomic medicine watchlists.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.